SCYNEXIS, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCYX research report →
About the company
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.
- CEO
- David Angulo
- IPO
- 2014
- Employees
- 18
- HQ
- Jersey City, NJ, US
Price Chart
- Market Cap
- $27.86M
- P/E
- -1.24
- P/S
- 1.37
- P/B
- 0.68
- EV/EBITDA
- 0.28
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -119.86%
- Net Margin
- -120.51%
- ROE
- -57.16%
- ROIC
- -39.18%
- Revenue
- $20.60M · 449.95%
- Net Income
- $-8,609,000 · 59.56%
- EPS
- $-1.36 · 61.36%
- Op Income
- $-16,074,000
- FCF YoY
- 78.00%
- 52W High
- $10.48
- 52W Low
- $3.68
- 50D MA
- $5.62
- 200D MA
- $6.05
- Beta
- 1.06
- Avg Volume
- 65.22K
Get TickerSpark's AI analysis on SCYX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 26, 26 | Tinmouth Brian Philippe | other | 2,875 |
| Jun 26, 26 | Tinmouth Brian Philippe | other | 2,875 |
| Jun 26, 26 | Macdonald Guy | other | 2,875 |
| Jun 26, 26 | Macdonald Guy | other | 2,875 |
| Jun 26, 26 | ANIDO ARMANDO | other | 2,875 |
| Jun 26, 26 | ANIDO ARMANDO | other | 2,875 |
| Jun 26, 26 | HASTINGS DAVID C | other | 2,875 |
| Jun 26, 26 | HASTINGS DAVID C | other | 2,875 |
| Jun 26, 26 | HANHAM ANN | other | 2,875 |
| Jun 26, 26 | HANHAM ANN | other | 2,875 |
Our SCYX coverage
Recent articles, reports, and earnings notes.
No research on SCYX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SCYX report →Similar companies
Peers in the same neighborhood.